Uzbekistan plans to produce coronavirus test kits based on samples from the American company Genscript, the Embassy of Uzbekistan in the United States reported.
“In order to create a diagnostic kit of reagents for detecting coronavirus, the Embassy of Uzbekistan in Washington agreed on the delivery of samples produced by the American company Genscript to the Center for Advanced Technologies at the Innovative Development Ministry of Uzbekistan for laboratory studies to identify coronavirus. These tests have been approved by the Center for Control and Prevention of Infectious Diseases of the US, and now they are planned to be used in organizing the production of Uzbekistan’s own test kits,” the report said.
At the same time, the embassy is negotiating with manufacturers of express tests - American companies Biomedomics and US Inc., as well as the University of Washington Medical Laboratory for delivery of samples to Uzbekistan.
US Inc., specializing in the development and production of innovative diagnostic tools, together with leading laboratories in the United States, China, South Korea, and Turkey, expressed its readiness to provide medical facilities in Uzbekistan with the necessary sets of test systems for the detection of coronavirus.
As previously reported, the United States Agency for International Development (USAID) announced the allocation of $37 million for 25 countries that are threatened by the new coronavirus COVID-19, including Uzbekistan.
These funds will assist countries in strengthening their capacity to prevent the spread of the infection. Within the framework of this program, the United States handed over sets of personal protective equipment (gloves, masks, insulating gowns and goggles) for distribution in the regions of Uzbekistan.